Your browser doesn't support javascript.
loading
Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients.
Da Col, Giacomo; Del Ben, Fabio; Bulfoni, Michela; Turetta, Matteo; Gerratana, Lorenzo; Bertozzi, Serena; Beltrami, Antonio Paolo; Cesselli, Daniela.
Afiliación
  • Da Col G; Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy.
  • Del Ben F; Department of Medicine, University of Udine, Udine, Italy.
  • Bulfoni M; Institute of Pathology, University Hospital of Udine (ASUFC), Udine, Italy.
  • Turetta M; Immunopathology and Cancer Biomarkers, Department of Translational Research, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Gerratana L; Department of Medicine, University of Udine, Udine, Italy.
  • Bertozzi S; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
  • Beltrami AP; Department of Surgery, AOU "S. Maria della Misericordia", Udine, Italy.
  • Cesselli D; Department of Medicine, University of Udine, Udine, Italy.
Front Oncol ; 12: 725318, 2022.
Article en En | MEDLINE | ID: mdl-35223462
BACKGROUND: The purpose of the present work was to test whether quantitative image analysis of circulating cells can provide useful clinical information targeting bone metastasis (BM) and overall survival (OS >30 months) in metastatic breast cancer (MBC). METHODS: Starting from cell images of epithelial circulating tumor cells (eCTC) and leukocytes (CD45pos) obtained with DEPArray, we identified the most significant features and applied single-variable and multi-variable methods, screening all combinations of four machine-learning approaches (Naïve Bayes, Logistic regression, Decision Trees, Random Forest). RESULTS: Best predictive features were circularity (OS) and diameter (BM), in both eCTC and CD45pos. Median difference in OS was 15 vs. 43 (months), p = 0.03 for eCTC and 19 vs. 36, p = 0.16 for CD45pos. Prediction for BM showed low accuracy (64%, 53%) but strong positive predictive value PPV (79%, 91%) for eCTC and CD45, respectively. Best machine learning model was Naïve Bayes, showing 46 vs 11 (months), p <0.0001 for eCTC; 12.5 vs. 45, p = 0.0004 for CD45pos and 11 vs. 45, p = 0.0003 for eCTC + CD45pos. BM prediction reached 91% accuracy with eCTC, 84% with CD45pos and 91% with combined model. CONCLUSIONS: Quantitative image analysis and machine learning models were effective methods to predict survival and metastatic pattern, with both eCTC and CD45pos containing significant and complementary information.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia